Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
After finishing at $0.41 in the prior trading day, Lyell Immunopharma Inc (NASDAQ: LYEL) closed at $0.40, down -2.05%. In other words, the price has decreased by -$2.05 from its previous closing price. On the day, 0.52 million shares were traded.
Ratios:
Our goal is to gain a better understanding of LYEL by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.49 and its Current Ratio is at 7.49. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.15.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on October 30, 2024, Downgraded its rating to Underperform and sets its target price to $1 from $6 previously.
On June 27, 2024, H.C. Wainwright Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $6 to $1.
JP Morgan Downgraded its Overweight to Neutral on August 28, 2023, whereas the target price for the stock was revised from $15 to $5.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 31 ’25 when BRAWLEY OTIS W bought 35,640 shares for $0.56 per share. The transaction valued at 19,958 led to the insider holds 35,640 shares of the business.
Ramachandra Sumant bought 200,000 shares of LYEL for $115,220 on Mar 21 ’25. The Director now owns 200,000 shares after completing the transaction at $0.58 per share. On Mar 14 ’25, another insider, Klausner Richard, who serves as the Director of the company, bought 158,000 shares for $0.60 each. As a result, the insider paid 94,942 and bolstered with 843,365 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1694.42 while its Price-to-Book (P/B) ratio in mrq is 0.35.
Stock Price History:
Over the past 52 weeks, LYEL has reached a high of $2.80, while it has fallen to a 52-week low of $0.39. The 50-Day Moving Average of the stock is -12.21%, while the 200-Day Moving Average is calculated to be -51.61%.
Shares Statistics:
A total of 295.28M shares are outstanding, with a floating share count of 120.25M. Insiders hold about 59.28% of the company’s shares, while institutions hold 21.59% stake in the company.
